Yamamoto, Suguru <br/><br/>
Oral activated charcoal adsorbent (AST-120) ameliorates extent and instability of atherosclerosis accelerated by kidney disease in apolipoprotein E-deficient mice.  [electronic resource] 

 -  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association  Aug 2011 
 - 2491-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1460-2385 
<br/><br/><label>Standard No.: </label>10.1093/ndt/gfq759  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Animals<br/>Apolipoproteins E--physiology<br/>Atherosclerosis--etiology<br/>Carbon--administration & dosage<br/>Charcoal--metabolism<br/>Chemokine CCL2--genetics<br/>Female<br/>Immunoenzyme Techniques<br/>Interleukin-1beta--genetics<br/>Kidney Diseases--complications<br/>Kidney Function Tests<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Knockout<br/>Oxides--administration & dosage<br/>RNA, Messenger--genetics<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Tumor Necrosis Factor-alpha--genetics